期刊文献+

不同病程帕金森病大鼠纹状体多巴胺转运蛋白的动态变化 被引量:1

The dynamic changes of striatal dopamine transporter in the progression of Parkinson's disease in rats
下载PDF
导出
摘要 目的:观察不同病程帕金森病(PD)大鼠纹状体多巴胺转运蛋白(DAT)的动态变化,并探讨该变化与黑质酪氨酸羟化酶(TH)之间的关系。方法:采用双点注射6-OHDA至大鼠右侧黑质致密部和前脑内侧束,建立偏侧PD模型。建模后2周、4周、6周的PD大鼠分别尾静脉注射99mTc-TRODAT-1,1h后取左右纹状体,以1计数仪测定放射性计数,并计算单位质量的左、右放射性计数率以及左、右纹状体单位质量的放射性计数比值。同时取建模后2周、4周、6周PD大鼠黑质组织进行TH免疫染色,观察阳性细胞形态及分布。结果:PD大鼠毁损侧纹状体放射计数明显低于健侧,建模后2周、4周、6周PD大鼠DAT相对放射计数较健侧分别降低了16.8%、35.9%和50.1%(P〈0.05~0.001);不同病程PD大鼠毁损侧纹状体DAT的相对放射计数与TH阳性细胞数呈高度的正相关(P〈0.01,R=0.9,n=15)。结论:PD大鼠纹状体DAT含量随着病程的增加逐渐减少,“Tc—PRO-DAT-1的放射性分布能够较准确的反映突触前多巴胺能神经元的变化。 Objective: To observe dynamic changes in striatal dopamine transporter (DAT) in progression of Parkinson 's disease (PD), and to investigate the relationships between changes of DAT and tyrosine hydroxylase (TH) expression in substantia nigra. Methods: A hemiparkinsonium rat model was established by a unilateral injection of 6-OHDA into the right substantia nigra pars compacta (SNc) and the right medial forebrain bundle (MFB). Rats were injected with ~mTc-TRODAT-1 through tail vein at 2, 4 and 6 weeks post-lesion, respectively. Both the left and right striata were re- moved after 1 h, the densities of DAT were measured using ~/radioactive counting meter, then the radioactive counts rate per unit mass of striatum on both sides and radioactivity of the striatum count ratio radioactive count on the right to that on the left sidie were calculated. Meanwhile, the morphology and distribution of TH immunoreactive positive cells in the sub- stantia nigra (SN) were observed at 2, 4 and 6 weeks post-lesion. Results: The radioactive counts on the lesioned side of SN in PD rats was significantly lower than that of unlesioned side, and it was decreased by 16.8% ,35.9% and 50.1% respectively when compared with the unlesioned side at 2, 4, and 6 weeks (P 〈 0.05 - O. 001, n = 5). There was a sig- nificant positive correlation between radioactive counts and TH immunoreactive positive cells in PD rats at 2, 4, and 6 weeks (P 〈0.01 ,R =0.9,n = 15). Conclusion: The density of DAT decreased gradually with the PD progression, and 99mTc-PRODAT-1 distribution of radioactivity may reflect the changes in presynaptic dopaminergic neurons.
出处 《神经解剖学杂志》 CAS CSCD 北大核心 2015年第4期399-402,共4页 Chinese Journal of Neuroanatomy
基金 国家自然科学基金(81241047) 福建省科技计划重点项目(2012Y0031)
关键词 帕金森病 多巴胺转运蛋白 多巴胺 酪氨酸羟化酶 Parkinson ' s disease melatonin dopamine tyrosine hydroxylase striatum substantia nigra 6 - OH-DA apomorphine DAT 99m Tc - PRODAT - 1
  • 相关文献

参考文献12

  • 1Park E, Hwang YM, Lee CN, et al. Differential Diagnosis of Pa- tients with Inconclusive Parkinsonian Features Using [ (18)F] FP- CIT PET/CT [ J]. Nucl Med Mol Imaging, 2014, 48:106 -1013.
  • 2Shen LH, Liao MH, Tseng YC. Recent advances in imaging of do- paminergic neurons for evaluation of neuropsychiatric disorders [ J]. J Biomed Biotechnol. 2012, 2012:259349.
  • 3Niethammer M, Tang CC, Ma Y, et al. Parkinson's disease cogni- tive network correlates with caudate dopamine [ J ]. Neuroimage, 2013, 78:204 - 209.
  • 4Suwijn SR, de Bruin K, de Bie RM, et al. The role of SPECT ima- ging of the dopaminergic system in translational research on Parkin- son's disease. Parkinsonism Relat Disord [J]. 2014, 20 Suppl 1: S184 - 186.
  • 5Chotibut T, Apple DM, Jefferis R, et al. Dopamine transporter loss in 6-OHDA Parkinson's model is unmet by parallel reduction in do- pamine uptake. PLoS One. 2012 ; 7 (12) : e52322.
  • 6Paxinos G, Watson C. The rat brain in stereotaxie coordinates [ M]. 4th, San Diego: Academic Press, 2006:235 - 246.
  • 7Hsiao IT, Weng YH, Lin WY, et al. Comparison of 99mTc-TRO- DAT-1 SPECT and 18 F-AV-133 PET imaging in healthy controls and Parkinson's disease patients [J]. Nuel Med Biol, 2014, 41: 322 - 329.
  • 8Wang L, Zhang Q, Li H, et al. SPECT molecular imaging in Par- kinsen's disease [J]. J Biomed Biotechnol, 2012, 2012:412486.
  • 9Seibyl J, Russell D, Jennings D, et al. The molecular basis of do- paminergic brain imaging in Parkinson's disease [J]. Q J Nucl Med Mol Imaging, 2012, 56:4 - 16.
  • 10Bobela W, Zheng L, Schneider BL. Overview of mouse models of Parkinson's disease. Curt Protoc Mouse Biol [ J] , 2014, 4 : 121 - 139.

二级参考文献12

  • 1Kish SJ, Tong J, Hornykiewicz O, et al. Preferential loss of serotonin markers in caudate versus putamen in Parkinson ' s disease. Brain, 2008,131:120-131.
  • 2Schernhammer E, Chert H, Ritz B. Circulating melatonin levels : possi- ble link between Parkinson' s disease and cancer risk? Cancer Causes Control ,2006,17:577-582.
  • 3Cadet JL, Brannock C, Krasnova IN, et al Methamphetamine-induced dopamine-independent alterations in striatal gene expression in the 6- hydroxydopamine hemiparkinsonian rats. PLoS One ,2010,5 : e15643.
  • 4Lin L, Meng T, Liu 'IT, et al Increased melatonin may play dual roles in the striata of a 6-hydroxydopamine model of Parkinson' s disease. Life Sci,2013,92:311-316.
  • 5Paxinos G, Watson C. The rat brain in stereotaxic coordinates. San Di- ego : Academic Press,2006.
  • 6Yuan H, Sarre S, Ebinger G, et al. Neuroprotective and neurotrophic effect of apomorphine in the striatal 6-OHDA-lesion rat model of Par- kinson' s disease. Brain Res ,2004 ,1026 :95-107.
  • 7Cheshire PA, Williams DR. Serotonergic involvement in levodopa-in- duced dyskinesias in Parkinsnn' s disease. J Clin Neurosci ,2012,19 : 343-348.
  • 8Politis M, Wu K, Loane C, et al. Staging of serotonergie dysfunction in Parkinson' s disease: an in vivo llC-DASB PET study. Neurobiol Dis,2010,40:216-221.
  • 9Singhal NK, Srivastava G, Agrawal S, et al. Melatonin as a neuropro- tective agent in the rodent models of Parkinson' s disease : is it all set to irrefutable clinical translation? Mol Neurobio1,2012,45 : 186-199.
  • 10Willis GL. Intraocular microinjections repair experimental Parkinson' s disease. Brain Res,2008 ,1217 :119-131.

共引文献4

同被引文献31

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部